NCT03174366View on ClinicalTrials.gov

Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

June 18, 2018

Study Completion Date

March 6, 2019

Conditions
Charcot Joint of Foot
Interventions
DRUG

Denosumab

Subjects will receive medication once following enrollment, and will be monitored for 1 year thereafter.

Trial Locations (1)

91711

Western University of Health Sciences, Pomona

All Listed Sponsors
lead

Western University of Health Sciences

OTHER

NCT03174366 - Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy | Biotech Hunter | Biotech Hunter